Inhibitors | Comment | Organism | Structure |
---|---|---|---|
benzyloxycarbonyl-ASTD-fluoromethylketone | 0.01 mM, complete inhibition of cleavage of pro-endothelial monocyte-activating polypeptide II | Mus musculus | |
benzyloxycarbonyl-DEVD-chloromethylketone | 0.01 mM, complete inhibition | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
pro-endothelial monocyte-activating polypeptide II + H2O | Mus musculus | caspase-7-mediated generation and release of mature endothelial monocyte-activating polypeptide II may provide a mechanism for leukocyte recruitment to sites of programmed cell death, and thus may link apoptosis to inflammation | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-ASTD-7-amido-4-methylcoumarin + H2O | - |
Mus musculus | acetyl-ASTD + 7-amino-4-methylcoumarin | - |
? | |
acetyl-DEVD-7-amido-4-methylcoumarin + H2O | - |
Mus musculus | acetyl-DEVD + 7-amino-4-methylcoumarin | - |
? | |
pro-endothelial monocyte-activating polypeptide II + H2O | pro-endothelial monocyte-activating polypeptide II in which the ASTD cleavage site is changed to the sequence ASTA, is not processed by caspase-7 | Mus musculus | endothelial monocyte-activating polypeptide II + ? | - |
? | |
pro-endothelial monocyte-activating polypeptide II + H2O | caspase-7-mediated generation and release of mature endothelial monocyte-activating polypeptide II may provide a mechanism for leukocyte recruitment to sites of programmed cell death, and thus may link apoptosis to inflammation | Mus musculus | ? | - |
? |